Gift, Life

Gift of Life Biologics and Cellex Cell Professionals GmbH Celebrate Successful Partnership to Deliver High-Quality Starting Materials for Final Drug Product Manufacturing in Cell and Gene Therapy

07.08.2025 - 18:08:51 | prnewswire.co.uk

Cellex Cell Professionals Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America Florida

and at www.giftoflife.org.

About Cellex Cell Professionals

Cellex Cell Professionals is a leading, full service CDMO specializing in CGT. With its state-of-the-art facilities located in Cologne, Germany, and a proven track record of 10+ years in GMP-compliant autologous and allogeneic cell therapy manufacturing, Cellex is partnered with several major pharma and innovative biotech companies supporting their process development and clinical and commercial manufacturing. In addition, Cellex offers customized starting materials from healthy donors and patients affected by specific conditions for research, clinical and commercial purposes as well as storage and logistics services.

Learn more at www.cellex.me/en.

Media Contacts:
Gift of Life:
Alec Burkin
Director of Business Development
aburkin@giftoflifebio.com | Phone +1 401.208.5951

Cellex Cell Professionals:
Phone: +49 221 2509 0
infocenter@cellex.me

Logo: https://mma.prnewswire.com/media/2646233/Gift_of_Life_Biologics_logo.jpg
Logo: https://mma.prnewswire.com/media/2621986/Cellex_Logo.jpg

 

Cellex Logo

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/gift-of-life-biologics-and-cellex-cell-professionals-gmbh-celebrate-successful-partnership-to-deliver-high-quality-starting-materials-for-final-drug-product-manufacturing-in-cell-and-gene-therapy-302408090.html

Anzeige

Wenn du diese Nachrichten liest, haben die Profis längst gehandelt. Wie groß ist dein Informationsrü

An der Börse entscheidet das Timing über Rendite. Wer sich nur auf allgemeine News verlässt, kauft oft dann, wenn die größten Gewinne bereits gemacht sind. Sichere dir jetzt den entscheidenden Vorsprung: Der Börsenbrief 'trading-notes' liefert dir dreimal wöchentlich datengestützte Trading-Empfehlungen direkt ins Postfach. Agiere vor der breiten Masse – 100% kostenlos und fundiert.
Jetzt abonnieren .